Jonathan Mizrahi, MD

Hematology-Oncology
Ochsner Clinic Foundation, United States

Presentation(s):

• Safety, Efficacy, and Outcomes of 90-Yttrium Radioembolization in Combination with Immune Checkpoint Inhibitors as a Definitive First-Line Treatment Approach in Non-Surgical Hepatocellular Carcinoma

  Monday, March 31, 2025
  4:03 PM – 4:12 PM CT